# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3062550 | F | Antifungal activity against Aspergillus by well diffusion method | Aspergillus | 3 | organism-based format | Scientific Literature | ||
2. | ALA3062551 | F | Antibacterial activity against Escherichia coli by well diffusion method | Escherichia coli | 3 | organism-based format | Scientific Literature | ||
3. | ALA3062023 | F | Antibacterial activity against Staphylococcus aureus by well diffusion method | Staphylococcus aureus | 3 | organism-based format | Scientific Literature | ||
4. | ALA3062563 | T | Ulcerogenic activity in Rattus norvegicus Wistar albino (rat) assessed as ulcer index at equimolar dose of relative to 200 mg/kg of ibuprofen, po after 17 hr | Rattus norvegicus | 3 | organism-based format | Scientific Literature | ||
5. | ALA3050936 | F | Antioxidant activity assessed as DPPH free radical scavenging activity at 100 ug/ml after 30 min | 8 | assay format | Scientific Literature | |||
6. | ALA3050937 | F | Analgesic activity in po dosed Mus musculus Swiss albino (mouse) assessed as increase in reaction time after 1.5 hr by tail-flick method relative to control | Mus musculus | 6 | organism-based format | Scientific Literature | ||
7. | ALA3050938 | F | Analgesic activity in po dosed Mus musculus Swiss albino (mouse) assessed as increase in reaction time after 1 hr by tail-flick method relative to control | Mus musculus | 6 | organism-based format | Scientific Literature | ||
8. | ALA3050939 | F | Analgesic activity in po dosed Mus musculus Swiss albino (mouse) assessed as increase in reaction time after 0.5 hr by tail-flick method relative to control | Mus musculus | 6 | organism-based format | Scientific Literature | ||
9. | ALA3050942 | F | Anti-inflammatory activity in Rattus norvegicus Wistar albino (rat) assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg, po administered 30 min before carrageenan challenge measured after 3 hr relative to control | Rattus norvegicus | 9 | organism-based format | Scientific Literature | ||
10. | ALA3050943 | F | Anti-inflammatory activity in Rattus norvegicus Wistar albino (rat) assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg, po administered 30 min before carrageenan challenge measured after 2.5 hr relative to control | Rattus norvegicus | 9 | organism-based format | Scientific Literature | ||
11. | ALA3050944 | F | Anti-inflammatory activity in Rattus norvegicus Wistar albino (rat) assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg, po administered 30 min before carrageenan challenge measured after 2 hr relative to control | Rattus norvegicus | 9 | organism-based format | Scientific Literature | ||
12. | ALA3050945 | F | Anti-inflammatory activity in Rattus norvegicus Wistar albino (rat) assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg, po administered 30 min before carrageenan challenge measured after 1.5 hr relative to control | Rattus norvegicus | 9 | organism-based format | Scientific Literature | ||
13. | ALA3051033 | F | Anti-inflammatory activity in Rattus norvegicus Wistar albino (rat) assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg, po administered 30 min before carrageenan challenge measured after 1 hr relative to control | Rattus norvegicus | 9 | organism-based format | Scientific Literature | ||
14. | ALA3047465 | F | Anti-inflammatory activity in Rattus norvegicus Wistar albino (rat) assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg, po administered 30 min before carrageenan challenge measured after 0.5 hr relative to control | Rattus norvegicus | 8 | organism-based format | Scientific Literature |